Testosterone is often described as the male hormone. That framing misses half the story. Testosterone in women plays a foundational role in energy, muscle mass, mood, cognition, libido, and bone strength across every stage of adult life. Women produce testosterone in smaller absolute quantities than men do, but the hormone remains just as biologically essential to female physiology. Testosterone levels in women decline steadily from the mid-20s onward, and the resulting symptoms often get attributed to age, stress, or general fatigue rather than the specific hormonal shift driving them. This blog post translates the science of female testosterone into a practical framework.
The Overlooked Female Hormone
Why Female Testosterone Was Ignored for So Long
Female testosterone has been under-studied and under-discussed for most of medical history. The consequences of that neglect show up in symptomatic women whose complaints are often dismissed rather than investigated. Medical research has historically focused on testosterone's role in men. Women's hormone research prioritized estrogen and progesterone, leaving testosterone as a footnote in most clinical guidelines. The result is a generation of women who received minimal education about a hormone that meaningfully shapes their daily experience of energy, mood, sexual function, and physical performance.
How Women Produce Testosterone
Women produce testosterone in two locations. The ovaries generate roughly half of the total daily output. The adrenal glands produce the other half, often from precursor hormones that later convert to testosterone in peripheral tissues. Women produce roughly one-tenth to one-fifteenth as much testosterone as men, but the hormone acts on the same receptors in similar tissues, producing meaningful biological effects at these lower levels.
The Current Shift in Clinical Attention
Modern research and clinical practice have begun to correct the historical gap. Guidelines from the Endocrine Society now address female testosterone specifically. Research groups have documented the hormone's role across female physiology in ways that older guidelines did not capture. The updated understanding is filtering into primary care, though many clinicians still receive limited training in this area.
What Testosterone Does in Women
Testosterone is an androgen, a class of hormones that influence muscle, mood, sexual function, cognition, and metabolic health. Understanding these roles helps women and clinicians recognize when symptoms may reflect underlying hormonal changes rather than isolated issues:
- Powering Physical Energy: Testosterone influences the sense of physical energy and drive that supports daily activity, exercise capacity, and general vitality. Women with adequate testosterone often report feeling more energized and motivated. The hormone works alongside thyroid function and adrenal output to determine the total energy state a woman experiences.
- Supporting Sexual Desire and Function: Testosterone regulates libido, sexual thought frequency, and arousal responsiveness in women. Declining testosterone during perimenopause and menopause contributes to reduced sexual interest that many women describe.
- Preserving Muscle and Bone: Testosterone signals muscle protein synthesis and supports bone mineral density. Women with adequate testosterone preserve strength and skeletal integrity better through midlife. The decline in testosterone during perimenopause contributes to the loss of muscle mass and bone density that shows up on scans during those years.
- Modulating Mood and Cognition: Testosterone influences mood, motivation, mental resilience, and cognitive processing speed. Women with low testosterone often describe lower baseline mood, reduced motivation, and increased mental fatigue.
- Contributing to Cardiovascular Health: Testosterone appears to influence cardiovascular function in women, though the relationship is more complex than in men. Very low levels are associated with adverse cardiovascular markers. Very high levels also produce risks. The optimal range lies within a middle band that supports heart and vascular health, as well as other hormonal functions throughout female physiology.
These roles overlap and reinforce each other. The consequence is that low female testosterone rarely produces a single symptom in isolation. Women more often describe a pattern of reduced vitality across multiple domains simultaneously.
How Female Testosterone Levels Change Over Time
Peak Levels in the 20s
Female testosterone follows a predictable pattern of decline across adult life. Female testosterone typically peaks in the mid-20s. Total testosterone at this stage sits around 30 to 70 nanograms per deciliter for most women, with variation based on individual physiology and testing methodology. The hormone supports the peak muscle mass, bone density, energy, and libido characteristic of these years.
The Steady Decline From 30 Onward
By age 40, average female testosterone has dropped roughly 50 percent from peak levels. The decline continues gradually through the following decades. Some women maintain relatively higher levels longer than others, and individual variation is substantial.
The Menopause Inflection Point
Menopause produces additional testosterone effects beyond the ongoing gradual decline. Ovarian production drops substantially, leaving the adrenal glands as the primary source. Some women experience a sharper drop in symptoms around this transition, while others experience a smoother continuation of the earlier decline pattern. The variability makes individualized assessment particularly important during this life stage.
Signs of Low Testosterone in Women
The Common Symptom Cluster
Symptoms of low female testosterone are non-specific, which is part of why the condition goes underdiagnosed. Recognizing the pattern of symptoms rather than any single one improves recognition. Reduced energy, lower libido, difficulty building or maintaining muscle, reduced motivation, and a blunted mood are classic symptoms. When these appear together in a woman who was previously higher-functioning, the pattern suggests a hormonal contribution that warrants testing. Individual symptoms in isolation could reflect many other causes, but the clustered pattern shifts the probability toward hormonal evaluation.
Why the Symptoms Often Get Misattributed
The same symptom cluster can look like depression, poor sleep, or general aging. Clinicians who do not test for testosterone specifically often miss the hormonal component entirely. Women themselves may attribute the changes to life stage or work stress without recognizing an underlying testable cause behind the pattern.
When to Suspect Testosterone Is the Issue
Symptoms that emerged relatively rapidly or that worsened notably during perimenopause point toward hormonal contribution. A history of previous ovarian surgery, chronic use of medications that affect hormone metabolism, or documented low levels on any prior testing all raise the probability that testosterone is contributing to current symptoms.
Perimenopause and Menopause Effects
The perimenopausal and menopausal transitions produce dramatic changes in female hormones:
- The Hormonal Cascade: Perimenopause typically begins in the mid-40s and continues until menopause is complete, usually a period of several years. During this time, estrogen levels fluctuate wildly, and testosterone continues its gradual descent.
- Where Testosterone Fits in the Larger Picture: Testosterone deficiency during and after menopause interacts with estrogen deficiency. Both contribute to bone loss, both influence mood, and both affect sexual function through overlapping but distinct pathways. Treating one without considering the other often produces incomplete symptom relief, which is a frequent reason women feel their hormone treatment is not fully working.
- Comprehensive Assessment: Assessment during perimenopause and menopause benefits from measuring all major hormones rather than focusing on a single hormone. Testosterone, estrogen, progesterone, thyroid hormones, and cortisol all interact.
Testing and Interpreting Female Testosterone
Total Testosterone vs. Free Testosterone
Hormone testing in women is more nuanced than in men. Total testosterone measures all testosterone in the blood, including the portion bound to proteins and unavailable to tissues. Free testosterone measures only the biologically active fraction. Both matter, and each provides different information. Testing both offers the most complete picture, though free testosterone measurement is more technically demanding, and results vary more across labs.
Sex Hormone Binding Globulin
Sex hormone binding globulin, often called SHBG, is the protein that carries testosterone through the bloodstream. High SHBG lowers free testosterone even when total testosterone appears normal. Low SHBG can raise free testosterone even when total testosterone levels appear unremarkable. Testing SHBG alongside total testosterone allows clinicians to calculate the free testosterone level more accurately than direct measurement in many cases.
Timing of Testing
Female testosterone shows some daily variation, with higher levels in the morning. Testing before 10 AM captures the higher end of the daily range. Menstrual cycle timing also matters for pre-menopausal women, with days 8 to 12 of the cycle typically providing the most reliable reading. Post-menopausal women can test at any time, given the loss of cyclical variation.
Comprehensive Hormone Assessment Beyond a Single Number
A single testosterone number rarely tells the complete story. Modern hormone health requires an integrated view of multiple markers and physiological patterns. Testosterone interacts with thyroid function, adrenal health, insulin sensitivity, inflammation, and other hormonal systems. Isolating testosterone from these other markers produces incomplete assessments and often incomplete treatment plans. The women who see the strongest outcomes work with comprehensive data across their full physiology rather than a single hormone in isolation.
Body composition reflects the cumulative effect of the entire hormonal environment. Loss of muscle mass, increased visceral fat, and reduced bone density all appear on a DEXA scan and often accompany declining testosterone levels and other hormonal shifts. Measuring body composition alongside hormone panels reveals patterns that either marker alone would miss. Comprehensive assessment produces personalized guidance rather than generic recommendations. BOD highlights this approach by combining biomarker testing through the HEALTH panel with body composition tracking. The pairing supports personalized health assessment rather than treating symptoms alone, which is the modern standard for evaluating female hormone health. These metrics together produce a picture that supports informed decisions about HRT, lifestyle changes, and monitoring strategies. Comprehensive testing is now widely available and represents the modern standard for evaluating female hormone health.
Treatment Approaches and Building a Personalized Plan
Lifestyle Foundations
Treatment options for female testosterone imbalance range from lifestyle interventions to prescription therapy. The right approach depends on symptom severity, life stage, individual goals, and the full hormonal and metabolic picture. Sleep, resistance training, stress management, and adequate protein intake all naturally support women's testosterone levels. Women in the mild-to-moderate symptom range often see meaningful improvements from optimizing these foundations before considering pharmaceutical options. Resistance training in particular preserves both muscle and hormone levels through midlife and provides broad additional health benefits beyond the hormonal domain.
The Role of Hormone Therapy
Testosterone therapy for women exists in various forms, including topical creams, injectable formulations, and pellet implants. Testosterone is not currently FDA-approved for women in the United States, though it is prescribed off-label and is approved for female hypoactive sexual desire disorder in several other countries. Testosterone therapy carries risks that require monitoring and should be undertaken only with qualified medical supervision that includes regular follow-up testing.
Building a Long-Term Approach
Female hormone health is a long game, not a single intervention. Symptoms shift across life stages, lab values change with age and lifestyle, and the appropriate strategy evolves accordingly. Working with qualified clinicians, monitoring objective data across time, and adjusting the approach based on how the body responds produces meaningfully better outcomes than any static protocol applied uniformly across years.
Female testosterone is one of the most under-appreciated components of women's health. The hormone shapes energy, muscle mass, mood, libido, cognition, and long-term bone and cardiovascular health across every stage of adult life. Understanding that levels decline steadily from the mid-20s onward, and often more sharply during perimenopause, empowers women to pursue appropriate testing before symptoms become disruptive. Symptoms of low female testosterone rarely appear in isolation, and comprehensive assessment across multiple hormonal and metabolic markers produces the clearest picture of what is actually happening in the body. Treatment options range from lifestyle foundations to targeted hormone therapy under qualified medical supervision, and the right path depends on individual physiology and goals rather than any generic protocol. Hormone health in women deserves the same rigorous attention as other aspects of health, and the tools now exist to support personalized approaches grounded in objective data rather than symptom management alone.
Sources
- Davis, S. R., & Wahlin-Jacobsen, S. (2015). Testosterone in women: the clinical significance. The Lancet Diabetes & Endocrinology, 3(12), 980-992. Doidoi.org/10.1016/S2213-8587(15)00284-3
- Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., & Santoro, N. (2014). Androgen therapy in women: A reappraisal - an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 99(10), 3489-3510. Doidoi.org/10.1210/jc.2014-2260
- Islam, R. M., Bell, R. J., Green, S., Page, M. J., & Davis, S. R. (2019). Safety and efficacy of testosterone for women: A systematic review and meta-analysis of randomized controlled trial data. The Lancet Diabetes & Endocrinology, 7(10), 754-766. Doidoi.org/10.1016/S2213-8587(19)30189-5
- Braunstein, G. D. (2007). Safety of testosterone treatment in postmenopausal women. Fertility and Sterility, 88(1), 1-17. Doidoi.org/10.1016/j.fertnstert.2007.01.118
- Vegunta, S., Kling, J. M., & Kapoor, E. (2020). Androgen therapy in women. Journal of Women's Health, 29(1), 57-64. Doidoi.org/10.1089/jwh.2018.7494